On estimation of bivariate biomarkers with known detection limits

Environmetrics

Volumn 19, Issue 3, 2008, Pages 301-317

  Chu, Haitao ^a   Nie, Lei ^b   Zhu, Motao ^c  

^a The University of North Carolina at Chapel Hill   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Correlation coefficient; Human immunodeficiency virus; Left censoring; Left truncation; Mixture model

Indexed keywords

BIOMARKER; CORRELATION; DETECTION METHOD; ESTIMATION METHOD; HUMAN IMMUNODEFICIENCY VIRUS; MEASUREMENT METHOD; MODELING; MONTE CARLO ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 42549123674     PISSN: 11804009     EISSN: 1099095X     Source Type: Journal    
DOI: 10.1002/env.868     Document Type: Article

References (36)

1. Barnhart HX, Song J, Lyles RH. 2005. Assay validation for left-censored data. Statistics in Medicine 24: 3347-3360.
2. Barroso PF, Schlechter M, Gupta P, Melo MF, Vieira M, Murta FC, Souza Y, Harrison LH. 2000. Effect of antiretroviral therapy on HIV shedding in semen. Annals of Internal Medicine 133: 280-284.
3. Berk KN, Lachenbruch PA. 2002. Repeated measures with zeros. Statistical Methods in Medical Research 11: 303-316.
4. Böhning D. 1998. Zero-inflated Poisson models and C.A.MAN: a tutorial collection of evidence. Biometrical Journal 40: 833-843.
5. Buchacz K, Pan CY, van der Straten A, Hanson CV, Padian N. 2000. HIV viral load and viral cultures in sexually active heterosexual man. Journal of Acquired Immune Deficiency Syndromes 23: 98-99.
6. Chu H, Ren S, Cole SR. 2004. Sample size calculations for the mean in a two compartment nonstandard mixture distribution. Biometrical Journal 46: 565-571.
7. Chu H, Nie L. 2005a. A note on comparing exposure data to a regulatory limit in the presence of unexposed and a limit of detection. Biometrical Journal 47: 880-887.
8. Chu H, Kensler TW, Muñoz A. 2005b. Assessing the effect of interventions in the context of mixture distributions with detection limits. Statistics in Medicine 24: 2053-2067.
9. Chu H, Moulton LH, Mack WJ, Passaro DJ, Barroso PF, Muñoz A. 2005. Correlating two continuous variables subject to detection limits in the context of mixture distributions. Journal of the Royal Statistical Society, Series C 54: 831-845.
10. Chu H, Nie L, Cole SR. 2006. Sample size and statistical power assessing the effect of interventions in the context of mixture distributions with detection limits. Statistics in Medicine 25: 2647-2657.
11. Dietz E, Bohning D. 2000. On estimation of the Poisson parameter in zero-modified Poisson models. Computational Statistics & Data Analysis 34: 441-459.
12. El-Shaarawi AH, Damsleth E. 1988. Parametric and nonparametric tests for dependent data. Water Resources Bulletin 24(3): 513-519.
13. El-Shaarawi AH. 1993. Environmental monitoring assessment and prediction of change. Environmetrics 4(2): 381-398.
14. Gibbons JD, Chakraborti S. 2003. Nonparametric Statistical Inference. 4th ed. Marcel Dekker Inc: New York.
15. Hall DB. 2000. Zero-inflated Poisson and binomial regression with random effects: a case study. Biometrics 56: 1030-1039.
16. Hildesheim A, Ryan RL, Rinehart E, Nayak S, Wallace D, Castle PE, Niwa S, Kopp W. 2002. Simultaneous measurement of several Cytokines using small volumes of biospecimens. Cancer Epidemiology Biomarkers Prevention 11: 1477-1484.
17. Ishiguro M, Sakamoto Y, Kitagawa G. 1997. Bootstrapping log-likelihood and EIC, an extension of AIC. Annals of the Institute of Statistical Mathematics 49: 411-434.
18. Khatri CG, Jaiswal MC. 1963. Estimation of parameters of a truncated bivariate normal distribution. Journal of the American Statistical Association 58: 519-526.
19. Kullback S, Leibler RA. 1951. On information and sufficiency. Annals of Mathematical Statistics 22: 79-86.
20. Lambert D. 1992. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics 34: 1-14.
21. Lyles RH, Williams JK, Chuachoowong R. 2001. Correlating two viral load assays with known detection limits. Biometrics 57: 1238-1244.
22. McLachlan GJ. 1987. On bootstrapping the likelihood ratio test statistics for the number of components in a normal mixture. Applied Statistics 36: 318-324.
23. McLachlan GJ, Peel D. 2001. Finite Mixture Models. John Wiley & Sons: New York.
24. Moulton LH, Halsey NA. 1995. A mixture model with detection limits for regression analyses of antibody response to vaccine. Biometrics 51: 1570-1578.
25. Moulton LH, Halsey NA. 1996. A mixed gamma model for regression analyses of quantitative assay data. Vaccine 14: 1154-1158.
26. Moulton LH, Curriero FC, Barroso PF. 2002. Mixture models for quantitative HIV RNA data. Statistical Methods in Medical Research 11: 317-325.
27. Nath BG. 1971. Estimating in truncated bivariate normal distributions. Applied Statistics 20: 313-319.
28. Nie L, Chu H, Cole SR. 2006. A general approach for sample size and statistical power calculations assessing the effects of interventions using a mixture model in the presence of a limit of detection. Contemporary Clinical Trials 27: 483-491.
29. Self SG, Liang KY. 1987. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard condition. Journal of the American Statistical Association 82: 605-610.
30. Smyth P. 2000. Model selection for probabilistic clustering using cross-validated likelihood. Statistics and Computing 10: 63-72.
31. Taylor DJ, Kupper LL, Rappaport SM, Lyles RH. 2001. A mixture for occupational exposure mean testing with a limit of detection. Biometrics 57: 681-688.
32. Titterington DM, Smith AFM, Makov UE. 1985. Statistical Analysis of Finite Mixture Distributions. John Wiley & Sons: New York.
33. Yau KKW, Lee AH. 2001. Zero-inflated Poisson regression regression with random effects to evaluate an occupational injury prevention program. Statistics in Medicine 20: 2907-2920.
34. Venables WN, Ripley BD. 2002. Modern Applied Statistics with S, 4th ed. Springer: New York.
35. Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GQ, Kuang SY, Zarba A, Egner PA, Jacobson LP, Munoz A, Helzlsouer KJ, Groopman JD, Kensler TW. 1999. Protective alterations in phase 1 and 2 metabolism of Aflatoxin b1 by Oltipraz in residents of Qidong, People's Republic of China. Journal of the National Cancer Institute 91: 347-354.
36. Wu MT, Simpson CD, Christiani DC, Hecht SS. 2002. Relationship of exposure to coke-oven emissions and urinary metabolites of Benzo(a)pyrene and Pyrene in coke-oven workers. Cancer Epidemiology Biomarkers Prevention 11: 311-314.